LS
TMO icon

Leelyn Smith’s Thermo Fisher Scientific TMO Stock Holding History

Leelyn Smith’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.87M Buy
9,712
+361
+4% +$173K 0.59% 48
2026
Q1 		$4.6M Buy
9,351
+475
+5% +$258K 0.64% 42
2025
Q4 		$5.14M Buy
8,876
+169
+2% +$95.6K 0.74% 34
2025
Q3 		$4.22M Buy
8,707
+501
+6% +$233K 0.64% 39
2025
Q2 		$3.33M Buy
8,206
+601
+8% +$251K 0.55% 46
2025
Q1 		$3.78M Buy
7,605
+397
+6% +$215K 0.67% 39
2024
Q4 		$3.75M Buy
7,208
+228
+3% +$125K 0.67% 39
2024
Q3 		$4.32M Buy
6,980
+257
+4% +$152K 0.78% 33
2024
Q2 		$3.72M Buy
6,723
+200
+3% +$115K 0.72% 36
2024
Q1 		$3.79M Buy
6,523
+159
+2% +$89.2K 0.76% 36
2023
Q4 		$3.38M Buy
6,364
+486
+8% +$235K 0.74% 37
2023
Q3 		$2.98M Buy
5,878
+290
+5% +$155K 0.73% 39
2023
Q2 		$2.92M Buy
+5,588
New +$3.02M 0.7% 38
2023
Q1 		– Sell
-150
Closed -$82.6K – 399
2022
Q4 		$82.6K Buy
150
+110
+275% +$58.3K 0.02% 139
2022
Q3 		$20K Sell
40
-550
-93% -$308K 0.01% 231
2022
Q2 		$320K Buy
590
+295
+100% +$162K 0.08% 103
2022
Q1 		$174K Hold
295
– – 0.05% 122
2021
Q4 		$197K Hold
295
– – 0.05% 118
2021
Q3 		$169K Hold
295
– – 0.05% 117
2021
Q2 		$149K Buy
295
+11
+4% +$5.19K 0.04% 133
2021
Q1 		$130K Hold
284
– – 0.04% 149
2020
Q4 		$132K Sell
284
-335
-54% -$157K 0.04% 140
2020
Q3 		$273K Hold
619
– – 0.1% 104
2020
Q2 		$224K Sell
619
-197
-24% -$66K 0.09% 109
2020
Q1 		$231K Sell
816
-65
-7% -$20.5K 0.12% 99
2019
Q4 		$289 Buy
+881
New +$267K 0.14% 94

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Leelyn Smith's TMO Position: Q2 2026 in Review

Leelyn Smith increased its Thermo Fisher Scientific (TMO) stake by 3.9% in Q2 2026, buying an estimated $173K and bringing the position to 9,712 shares worth $4.87M. The position accounts for 0.59% of the portfolio, ranked #48.

Leelyn Smith first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.14M in Q4 2025. 1,184 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Leelyn Smith held 9,712 shares of Thermo Fisher Scientific worth $4.87M as of Q2 2026.
  • Leelyn Smith bought 361 Thermo Fisher Scientific shares in Q2 2026, an estimated $173K.
  • Thermo Fisher Scientific made up 0.59% of Leelyn Smith's portfolio in Q2 2026, its #48 holding.
  • Leelyn Smith first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • Leelyn Smith's Thermo Fisher Scientific position peaked at $5.14M in Q4 2025.
  • 1,184 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.